Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Takeuchi

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Blood|October 23, 2024
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myelomaDaisuke Ikeda, Shuichi Aikawa, Chiho Misono, et al.
Haematologica|January 9, 2025
Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myelomaMasanori Toho, Daisuke Ikeda, Shuichi Aikawa, et al.
International Journal of Hematology|February 21, 2022
Antibody response to COVID-19 vaccination in patients with lymphomaKentaro Narita, So Nakaji, Rikako Tabata, et al.
British Journal of Haematology|July 19, 2013
Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopeniaShokichi Tsukamoto, Chiaki Nakaseko, Masahiro Takeuchi, et al.
International Journal of Hematology|February 22, 2022
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myelomaToshiki Terao, Takeshi Yamashita, Ami Fukumoto, et al.
British Journal of Haematology|August 16, 2005
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasmsNaoko Murashige, Masahiro Kami, Yukiko Kishi, et al.
Haematologica|February 24, 2018
Liquid biopsy for the identification of intravascular large B-cell lymphomaYasuhito Suehara, Mamiko Sakata-Yanagimoto, Keiichiro Hattori, et al.
British Journal of Haematology|July 28, 2021
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survivalTakeshi Yamashita, Hiroyuki Takamatsu, Koji Kawamura, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Blood|October 23, 2024
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myelomaDaisuke Ikeda, Shuichi Aikawa, Chiho Misono, et al.
Haematologica|January 9, 2025
Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myelomaMasanori Toho, Daisuke Ikeda, Shuichi Aikawa, et al.
International Journal of Hematology|February 21, 2022
Antibody response to COVID-19 vaccination in patients with lymphomaKentaro Narita, So Nakaji, Rikako Tabata, et al.
British Journal of Haematology|July 19, 2013
Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopeniaShokichi Tsukamoto, Chiaki Nakaseko, Masahiro Takeuchi, et al.
International Journal of Hematology|February 22, 2022
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myelomaToshiki Terao, Takeshi Yamashita, Ami Fukumoto, et al.
British Journal of Haematology|August 16, 2005
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasmsNaoko Murashige, Masahiro Kami, Yukiko Kishi, et al.
Haematologica|February 24, 2018
Liquid biopsy for the identification of intravascular large B-cell lymphomaYasuhito Suehara, Mamiko Sakata-Yanagimoto, Keiichiro Hattori, et al.
British Journal of Haematology|July 28, 2021
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survivalTakeshi Yamashita, Hiroyuki Takamatsu, Koji Kawamura, et al.
Pageof 12